| Application number | Title of the application | Filing Date | Status |
|---|
| 09/958856 | Dna molecules encoding human endothelin converting enzyme 3 | Oct 11, 2001 | Abandoned |
Array
(
[id] => 5859100
[patent_doc_number] => 20020123124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Highly productive alpha-amylases'
[patent_app_type] => new
[patent_app_number] => 09/971611
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7576
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123124.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971611 | Highly productive alpha-amylases | Oct 8, 2001 | Issued |
Array
(
[id] => 6561389
[patent_doc_number] => 20020164746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => '47174, a novel human glycosyltransferase and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/973457
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 43517
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164746.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973457
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973457 | 47174, a novel human glycosyltransferase and uses thereof | Oct 8, 2001 | Issued |
Array
(
[id] => 6537116
[patent_doc_number] => 20020137146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Novel expression vectors for production of foreign proteins as soluble forms'
[patent_app_type] => new
[patent_app_number] => 09/974248
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5943
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137146.pdf
[firstpage_image] =>[orig_patent_app_number] => 09974248
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/974248 | Expression vectors for production of foreign proteins as soluble forms | Oct 8, 2001 | Issued |
| 09/869155 | Proteins | Sep 30, 2001 | Abandoned |
Array
(
[id] => 1022038
[patent_doc_number] => 06887979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-03
[patent_title] => 'Method of preventing decrease in the activity of protein due to freezing and use of polypeptide in the production of protein activity decrease preventing agent'
[patent_app_type] => utility
[patent_app_number] => 10/148306
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6044
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148306
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148306 | Method of preventing decrease in the activity of protein due to freezing and use of polypeptide in the production of protein activity decrease preventing agent | Sep 30, 2001 | Issued |
Array
(
[id] => 442629
[patent_doc_number] => 07256031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => 'Enzyme having β-glucosidase activity and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/381434
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9558
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/256/07256031.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381434
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381434 | Enzyme having β-glucosidase activity and use thereof | Sep 27, 2001 | Issued |
Array
(
[id] => 6358657
[patent_doc_number] => 20020058313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Use of recombinant enzymes for preparing GDP-L-fucose and fucosylated glycans'
[patent_app_type] => new
[patent_app_number] => 09/962805
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12264
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058313.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962805
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962805 | Use of recombinant enzymes for preparing GDP-L-fucose and fucosylated glycans | Sep 25, 2001 | Abandoned |
Array
(
[id] => 6870090
[patent_doc_number] => 20030082779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'BGL3 beta-glucosidase and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/957880
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15481
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082779.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957880
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957880 | Trichoderma β-glucosidase | Sep 20, 2001 | Issued |
Array
(
[id] => 6095825
[patent_doc_number] => 20020052046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Method of improving the primary energy metabolism of mammalian cell lines'
[patent_app_type] => new
[patent_app_number] => 09/954243
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4390
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052046.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954243
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954243 | Method of improving the primary energy metabolism of mammalian cell lines | Sep 16, 2001 | Issued |
Array
(
[id] => 6592777
[patent_doc_number] => 20020042046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex'
[patent_app_type] => new
[patent_app_number] => 09/952975
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 7229
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042046.pdf
[firstpage_image] =>[orig_patent_app_number] => 09952975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/952975 | Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex | Sep 13, 2001 | Abandoned |
Array
(
[id] => 1148854
[patent_doc_number] => 06770475
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-03
[patent_title] => 'Promoters'
[patent_app_type] => B1
[patent_app_number] => 09/936145
[patent_app_country] => US
[patent_app_date] => 2001-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8028
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770475.pdf
[firstpage_image] =>[orig_patent_app_number] => 09936145
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/936145 | Promoters | Sep 6, 2001 | Issued |
Array
(
[id] => 5923975
[patent_doc_number] => 20020115839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => '8797, a novel human galactosyltransferase and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/945254
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 41966
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115839.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945254
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945254 | 8797, a novel human galactosyltransferase and uses thereof | Aug 30, 2001 | Abandoned |
Array
(
[id] => 6720834
[patent_doc_number] => 20030054522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Genomic sequence of NGR234 symbiotic plasmid, its gene map, and its use in diagnostics and gene transfer in agriculture'
[patent_app_type] => new
[patent_app_number] => 09/939964
[patent_app_country] => US
[patent_app_date] => 2001-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 149
[patent_figures_cnt] => 149
[patent_no_of_words] => 25077
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054522.pdf
[firstpage_image] =>[orig_patent_app_number] => 09939964
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/939964 | Genomic sequence of NGR234 symbiotic plasmid, its gene map, and its use in diagnostics and gene transfer in agriculture | Aug 26, 2001 | Abandoned |
Array
(
[id] => 1092631
[patent_doc_number] => 06825017
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-30
[patent_title] => 'Desaturases and methods of using them for synthesis of polyunsaturated fatty acids'
[patent_app_type] => B1
[patent_app_number] => 09/857583
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 20500
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825017.pdf
[firstpage_image] =>[orig_patent_app_number] => 09857583
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/857583 | Desaturases and methods of using them for synthesis of polyunsaturated fatty acids | Aug 16, 2001 | Issued |
Array
(
[id] => 6342567
[patent_doc_number] => 20020034810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity'
[patent_app_type] => new
[patent_app_number] => 09/930218
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16747
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034810.pdf
[firstpage_image] =>[orig_patent_app_number] => 09930218
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/930218 | Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity | Aug 15, 2001 | Issued |
Array
(
[id] => 963560
[patent_doc_number] => 06949372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Engineering intracellular sialylation pathways'
[patent_app_type] => utility
[patent_app_number] => 09/930440
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 53
[patent_no_of_words] => 36119
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949372.pdf
[firstpage_image] =>[orig_patent_app_number] => 09930440
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/930440 | Engineering intracellular sialylation pathways | Aug 15, 2001 | Issued |
Array
(
[id] => 6358661
[patent_doc_number] => 20020058314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'DNA coding for protein which confers on bacterium escherichia coli resistance to L-homoserine, and method for producing L-amino acids'
[patent_app_type] => new
[patent_app_number] => 09/927395
[patent_app_country] => US
[patent_app_date] => 2001-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5556
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058314.pdf
[firstpage_image] =>[orig_patent_app_number] => 09927395
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/927395 | DNA coding for protein which confers on bacterium escherichia coli resistance to L-homoserine, and method for producing L-amino acids | Aug 12, 2001 | Abandoned |
Array
(
[id] => 6528591
[patent_doc_number] => 20020192793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Isolation of the biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use'
[patent_app_type] => new
[patent_app_number] => 09/922683
[patent_app_country] => US
[patent_app_date] => 2001-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9270
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192793.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922683
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922683 | Isolation of biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use | Aug 6, 2001 | Issued |
Array
(
[id] => 6446407
[patent_doc_number] => 20020177209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy'
[patent_app_type] => new
[patent_app_number] => 09/922067
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7356
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177209.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922067
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922067 | Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy | Aug 2, 2001 | Issued |